We pioneer breakthroughs in healthcare. For everyone. Everywhere. Learn more about our purpose, our innovation leadership, our culture, and our strategy.
In this episode, we hear how some of the innovations that came with the COVID-19 pandemic could now be used to create a more sustainable and resilient healthcare system globally.
Accelerating the cancer care path
Starting radiotherapy in hours instead of weeks
Patients undergoing radiation often have to wait weeks, if not months, for their cancer treatment to begin. Learn how intelligent technology can help reduce the time between diagnosis and start of treatment for dedicated patient groups, and thus change the course of precision cancer care.
Delivering high-value care
Leading the way in cancer care
Effective cancer care requires strong leadership. This paper identifies and examines leadership approaches that will be essential in the rapidly changing oncology landscape of tomorrow.
Learn about burden of non-communicable diseases like cancer and heart disease in middle-income and developing countries. Hear about new ways to improve access to care in these countries and learn how the World Economic Forum and the City Cancer Challenge Foundation push for meaningful change.
Digital twins in cancer care
00
Digital twins in cancer care
0:000:00
0:00
Find out how digital twins could transform the entire cancer care path – from early detection to treatment and follow-up care. You’ll also learn how a digital twin of an organ is created. And you’ll hear what digital twin technology could mean for patients, clinicians, and the future of oncology.
of all critical clinical decisions are influenced by our solutions. We are at the center of clinical decision making.
90%
of leading hospitals have chosen to give us their trust and work with us. We collaborate with researchers, partners, caregivers, and global institutions.
In more than 70
countries around the globe – that's where we are present, making sure we are close to our customers. Our products, solutions, and services are customized to local market needs, benefiting from an unmatched global expertise.
€1.5 billion
is our annual investment into research and development. (FY 2021)
technical intellectual property rights, thereof more than 14,000 granted patents; constantly bringing breakthrough innovations to market – for the benefit of patients, medical professionals, and society. (As of Oktober 2021)
